SLU-PP-332

🔬

SLU-PP-332

ERR agonist · Exercise mimetic peptide

Preclinical📈 Trendingmetabolic

Potent ERRα/γ agonist that mimics endurance exercise physiology — increases VO2 max and fat oxidation in animal studies.

Half-Life

~4–6 hours (estimated)

MW

N/A

Amino Acids

N/A

Evidence

Preclinical

Regulatory Status

Research compound only

In Plain English

Flips the same metabolic switches that endurance exercise does — boosting mitochondria and fat burning without the actual exercise. Mouse studies showed 70% improved running endurance. Pure preclinical research territory with no human data.

Overview

SLU-PP-332 is a small molecule/peptide-derived compound that powerfully activates estrogen-related receptors (ERRα, ERRβ, ERRγ), which are master regulators of mitochondrial biogenesis and exercise response. Studies show dramatic improvements in running endurance (70% increase in mice), heart function, and metabolic fitness. Often discussed as the closest thing to an "exercise in a pill" in current research.

Common Formats

  • Injectable (research)

Storage Notes

Store at -20°C. Limited stability data.

Looking for multi-compound protocols?

Browse educational protocol discussions that include SLU-PP-332.

Protocol Library

Research Sources

(3 vendors)

For research use only. No affiliation or endorsement implied.

Related Compounds

Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.